In April 2022 the French Anti-Doping Agency (AFLD) has reported an anti-doping rule violation against the Kenyan Athlete after his sample - provided in March 2022 - tested positive for the prohibited substance Methasterone.
Thereupon in October 2022 the Athletics Integrity Unit (AIU) on behalf of World Athletics has reported anti-doping rule violations against the Athlete after his two samples - provided in April and in May 2022 - also tested positive for Methasterone.
After notification both AFLD and AIU ordered a provisional suspension on the Athlete. In September 2022 the AFLD transferred its case to the AIU for reasons of procedural efficiency.
Previously in May 2022 the AFLD had contacted the Athlete about the first positve test and reported that he had participated in two competitions during the Provisional Suspension. The Athlete explained that he was unaware of the Notification and Provisional Suspension.
The Athlete produced evidence regarding the medical treatment he underwent in March 2022, yet the AFLD determined that this treatment could not explain the presence of Methasterone in his sample. Further the AIU established that the Athlete's 3rd positive test could not have been caused by a single administration of Methasterone in March 2022.
Ultimately in October 2022 the Athlete admitted the violation, waived his right for a hearing and accepted the sanction proposed by the AIU. Because the Athlete signed and submitted the Admission of Anti-Doping Rule Violations and Acceptance of Consequences Form he received a 1 year reduction from the AIU.
In view of the evidence the AIU deemed that there were grounds for the application of aggravating circumstances because the Athlete had used a prohibited substance on multiple occasions. Therefore the AIU decides on 11 November 2022 to impose a 5 year period of ineligibility on the Athlete, starting on 13 May 2022.
